ITEM 1A. RISK FACTORS 12/7/2023 Form: 10-K - Annual Report ITEM 1A.RISK FACTORS.
Summary of Risk Factors
Our business is subject to numerous risks and uncertainties, discussed in more detail in the following section. These risks include, among others, the following key risks:
| | | We have produced limited revenue. This makes it difficult to evaluate our future prospects and increase the risk that we will not be successful. |
| | | There is substantial doubt relating to our ability to continue as a going concern. |
| | | Our opportunities to work with customers to develop pharmaceuticals and biologics will require substantial additional funding. Our customers may not be successful in their efforts to create a pipeline of product candidates, to develop commercially successful products, or to develop commercially successful biologic production. |
| | | We may not successfully implement our business strategies, including achieving our growth objectives. |
| | | We may require additional financing which may in turn require the issuance of additional shares of common stock, preferred stock or other debt or equity securities (including convertible securities) and which would dilute the ownership held by or stockholders. |
| | | Our operating results have been and could be adversely affected by a reduction in business with our significant customers. |
| | | We may encounter difficulties in managing our growth and these difficulties could impair our profitability. |
| | | Our current emphasis on Therapeutic DNA Production Services may reduce our ability to maintain and expand our existing MDX Testing Services and DNA Tagging and Security Products and Services businesses. |